Public Health Home Health Inc Location: 3169 Inner Perimeter Road, Valdosta, Georgia 31602 Ratings: Phone: (229) 253-1242 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Georgia Home Health Services Location: 4380 Kings Way, Valdosta, Georgia 31602 Ratings: Phone: (229) 247-4665 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Intrepid Usa Healthcare Services Location: 355 Northside Drive, Valdosta, Georgia 31602 Ratings: Phone: (229) 247-7760 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Amedisys Home Health Of Valdosta Location: 2947 North Ashley Street, Suite C, Valdosta, Georgia 31602 Ratings: Phone: (229) 245-0646 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
Several of Cancer Research UK's scientists have been named on this year's New Year's Honours list, as has the government's National Cancer Director and a long-term supporter of the charity.
Cancer patients treated with the chemotherapy agent bevacizumab may be at an increased risk of treatment-related death when the drug is used in combination with other therapies.
In releasing a new report on maternal health nationwide, Amnesty International today revealed that flaws and shocking disparities in maternal health care that the government is ignoring lead to two to three women dying daily in the United States from pregnancy-related complications, with half of these deaths believed preventable, according to the Centers for Disease Control. A state-by-state examination shows that New Jersey is 35th on a maternal mortality ranking, with 11.3 deaths per 100,000 live births.
Merit Medical Systems, Inc. today announced the completion of its acquisition of BioSphere Medical, Inc., a leading developer and marketer of embolotherapeutic products for the treatment of uterine fibroids, hypervascularized tumors, and arteriovenous malformations.
MDX-1303 was developed by Medarex using its UltiMAb Human Antibody Development System, and this antibody is currently in preclinical development by Medarex for use against human anthrax infection.
› Verified 9 days ago